• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Extracellular matrix as a new therapeutic target for choroidal neovascularization

Research Project

Project/Area Number 21592237
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Ophthalmology
Research InstitutionNagoya City University

Principal Investigator

NOZAKI Miho  名古屋市立大学, 大学院・医学研究科, 講師 (00295601)

Co-Investigator(Kenkyū-buntansha) OGURA Yuichiro  名古屋市立大学, 大学院・医学研究科, 教授 (70191963)
YASUKAWA Tsutomu  名古屋市立大学, 大学院・医学研究科, 准教授 (00324632)
Project Period (FY) 2009 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords加齢黄斑変性 / 脈絡膜新生血管 / VEGF-A / オステオポンチン / マクロファージ / 細胞外マトリックス / VEGF
Research Abstract

Osteopontin(OPN) is a chemokine like phospholyrated glycoprotein and involved in inflammation, tumor genesis and wound healing. The purpose of the study was to clarify a role of OPN in the development of laser-induced choroidal neovascularization(CNV) in mice. OPN neutralizing Abs significantly abolished CNV area. Genetic ablation of OPN also significantly suppressed CNV area compared with wild-type mice. OPN was immunopositive in the CNV lesions and co-localized with infiltrated macrophages. Collectively these findings demonstrate a significant role of OPN in the development of CNV. OPN blockade may be considered further therapeutic potential for age-related macular degeneration.

Report

(4 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (11 results)

All 2011 2010 2009

All Journal Article (6 results) (of which Peer Reviewed: 6 results) Presentation (5 results)

  • [Journal Article] Non-targeted siRNA suppresses laser-induced choroidal neovascularization2010

    • Author(s)
      Shikari M, Tokoro M, Itaya M, Nozaki M, Ogura Y
    • Journal Title

      Invest Ophthalmol Vis Sci

      Volume: 51巻 Pages: 3820-3824

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Non-targeted siRNA suppresses laser-induced choroidal neovascularization.2010

    • Author(s)
      Ashikari M, Tokoro M, Itaya M, Nozaki M, Ogura Y
    • Journal Title

      Invest Ophthalmol Vis Sci

      Volume: 51 Pages: 3820-3824

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Non-targeted siRNA suppresses laser-induced choroidal neovascularization2010

    • Author(s)
      Ashikari M, Tokoro M, Itaya M, Nozaki M, Ogura Y
    • Journal Title

      Invest Ophthalmol Vis Sci (Epub)

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] CCR3 is a target for age-related macular degeneration diagnosis and therapy2009

    • Author(s)
      Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Green MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati J
    • Journal Title

      Nature

      Volume: 460巻 Pages: 225-230

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] CCR3 is a target for age-related macular degeneration diagnosis and therapy2009

    • Author(s)
      Takeda A, Nozaki M, Ogura Y, et al
    • Journal Title

      Nature 460

      Pages: 225-230

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth2009

    • Author(s)
      Cho WG, Nozaki M, et al
    • Journal Title

      Proc Natl Acad Sci USA 106

      Pages: 7137-7142

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Presentation] Anti-angiogenic effct of IFN-gamma and IL-12 on laser-induced choroidal neovascularizationmodel in mice2011

    • Author(s)
      Masayuki Ashikari, Miho Nozaki, Takeshi Mizutani, Yuichiro Ogura
    • Organizer
      ARVO 2011
    • Place of Presentation
      フォートローダーデール(アメリカ)
    • Related Report
      2011 Final Research Report
  • [Presentation] Anti-angiogenic effect of fidarestat on laser-induced choroidal neovascularizationin mice2011

    • Author(s)
      Miho Nozaki, Atsushi Nakajima, Nobutaka Morimoto, Noriaki Kato, Yuichiro Ogura
    • Organizer
      ARVO 2011
    • Place of Presentation
      フォートローダーデール(アメリカ)
    • Related Report
      2011 Final Research Report
  • [Presentation] Oral Anti-Cytokine Therapy for AMD : Fidarestat Suppresses Laser-Induced Choroidal Neovascularization in Mice.2010

    • Author(s)
      Sugitani K, Nozaki M, Nakajima A, Morimoto N, Kato N, Ogura Y
    • Organizer
      ARVO (Annual meeting of the Association for Research in Vision and Ophthalmology)
    • Place of Presentation
      ブロワードコンベンションセンター(米国)
    • Year and Date
      2010-05-05
    • Related Report
      2010 Annual Research Report
  • [Presentation] CCR3 antagonist suppresses laser-induced choroidal neovascularization in mice2010

    • Author(s)
      Masayuki Ashikari, Mayumi Tokoro, Miho Nozaki, Yuichiro Ogura
    • Organizer
      Euretina
    • Place of Presentation
      パリ(フランス)
    • Related Report
      2011 Final Research Report
  • [Presentation] オステオポンチン阻害による脈絡膜新生血管抑制2009

    • Author(s)
      所真由美, 野崎実穂, 他
    • Organizer
      第113回日本眼科学会総会
    • Place of Presentation
      東京国際フォーラム(東京)
    • Year and Date
      2009-04-16
    • Related Report
      2009 Annual Research Report

URL: 

Published: 2009-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi